Drawing for DGH

USPTO serial 98273074

DGH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HAYNES, SAMANTHA M
Law office
TMO LAW OFFICE 125

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DGH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amanda H. Wilcox

200 PUBLIC SQUARE, SUITE 3500CLEVELAND, OH 44114UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Cells for medical use; Clinical medical reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Culture media for cultivating human blood cells; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposesACTIVEJun 27, 2007
042Custom design and development of chemical reagents and biochemical assays; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research in the field of oncology; Medical research services; Scientific research; Scientific research and development; Scientific research consulting; Scientific research in the field of genetics and genetic engineering; Genetic testing for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseasesACTIVEJun 27, 2007
044DNA screening for medical purposesACTIVEJun 27, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 8, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 8, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 24, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2024DOCKASSIGNED TO EXAMINER—
Dec 21, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance